Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. UPLOAD Other SEC-generated Letter
  2. S-3 Offering Registration Statement
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale 10% owner sold 1,963 shares at $1.05 ($2,061)
  8. 4 Open-market sale Director sold 2,425 shares at $1.05 ($2,546)
  9. 4 Open-market sale 10% owner sold 4,386 shares at $1.05 ($4,605)
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 3 Insider Initial Statement of Ownership
  14. 424B5 Offering Prospectus
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. 8-K Event Executive or director change
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 12 of 23 · 453 filings